Pioneering startup in AI-driven prognosis tests for cancer treatment Spotlight Medical announced on Friday a EUR6.2m seed funding round led by Kurma Partners and Heal Capital.

This funding will bring its first prognosis test to the clinic, marking a significant milestone in commercializing AI-based cancer solutions. Spotlight Medical leverages decades of patient treatment data to prevent over or undertreatment, enhancing cancer outcomes.

Founded in 2024, Spotlight Medical is supported by esteemed cancer centres Institut Curie and Gustave Roussy. The company is dedicated to developing clinical tests that utilize vast patient data.

Advanced AI algorithms will provide a concrete AI-based solution for cancer patients, significantly improving treatment precision.